Skip to main content

Day: August 6, 2020

Mortgage Rates Drop, Hitting a Record Low for the Eighth Time this Year

MCLEAN, Va., Aug. 06, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.88 percent, the lowest rate in the survey’s history dating back to 1971.“The resilience of the housing market continues as mortgage rates hit another all-time low, giving potential buyers more purchasing power and strengthening demand,” said Sam Khater, Freddie Mac’s Chief Economist. “We expect rates to stay low and continue to propel the purchase market forward. However, the main barrier to rising demand remains the lack of inventory, especially for entry-level homes.”News Facts30-year fixed-rate mortgage averaged 2.88 percent with an average 0.8 point for the week ending August 6, 2020, down from last week when it averaged...

Continue reading

Liquid Media Retains Novus Merchant Partners as its Capital Markets Advisor

VANCOUVER, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) is pleased to announce it has retained Novus Merchant Partners Inc. (“Novus”) as its capital markets advisor.  Novus will assist the Company in developing, implementing and executing on its business strategy of consolidating and vertically integrating intellectual property (IP) rights with production capabilities to leverage innovative technology as well as owned IP into full media franchises.  As part of its mandate, Novus will act as financial advisor to the Company on strategic M&A transactions.Novus is a merchant and investment banking firm co-founded by Charles Shin and Ron Rimer, who together have led or co-led over USD$10.5-billion in financing and M&A transactions. Novus’s...

Continue reading

Hemp, Inc. Surpasses $2 Million in Sales From Its Premium, High Quality Hemp Flower

Las Vegas, NV, Aug. 06, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) announced today that sales to date, from their premium hemp flower, Pre-98 OG Bubba Kush, have surpassed their $2,000,000 groundbreaking milestone.  The Company has reached $2,098,117.04 (up $1,062,300 from sales reported, after surpassing its first milestone of $1,000,000, in a past press release on 5/26/20). That’s a total increase of $1,062,300 over the past ten weeks.  The Company expects to hit groundbreaking milestones quarterly, with other products to come.Hemp, Inc.’s CEO, Bruce Perlowin, admits it was very frustrating and full of delays during the first quarter due to the COVID-19 pandemic but says the Company has been “full speed ahead” since then.  “We’ve also started our mass marketing campaigns so I’m certain we will...

Continue reading

Delårsmeddelelse

Nasdaq Copenhagen A/S                                                      Meddelelse nr.                           6/2020Nicolai Plads 6                                                     Fondskode.                DK 00102835971007 København K                                                CVR nr.                                 15313714                                                                             LEI kode:      990  0NJCIEGWTL0U036                                       Kontaktperson                                                                               Peter Hansen           Tlf. 36931011        Delårsrapport for perioden 1. januar – 30. juni 2020 og forventning til resultatet for 2020Andersen & Martini realiserer et underskud på godt t.kr. 300 før skat i første halvår 2020 og forventer et resultat...

Continue reading

Delårsmeddelelse 2020

Nasdaq Copenhagen A/S                                                      Meddelelse nr.                           6/2020Nicolai Plads 6                                                     Fondskode.                DK 00102835971007 København K                                                CVR nr.                                 15313714                                                                             LEI kode:      990  0NJCIEGWTL0U036                                       Kontaktperson                                                                               Peter Hansen           Tlf. 36931011        Delårsrapport for perioden 1. januar – 30. juni 2020 og forventning til resultatet for 2020Andersen & Martini realiserer et underskud på godt t.kr. 300 før skat i første halvår 2020 og forventer et resultat...

Continue reading

Amarin annonce ses projets pour maximiser le potentiel révolutionnaire de VASCEPA® (icosapent éthyl) en Europe

Amarin va créer une organisation dédiée pour conserver une valeur substantielle de l’un des médicaments cardiovasculaires les plus attendus depuis des décenniesUn dirigeant commercial chevronné spécialisé dans les maladies cardiovasculaires a été engagé pour mener le lancement cibléDUBLIN, Irlande et BRIDGEWATER, New Jersey, 06 août 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ : AMRN) a annoncé aujourd’hui les projets de la société pour entreprendre son propre lancement commercial ciblé de VASCEPA® ( icosapent éthyl) en Europe.  Le projet d’Amarin est soumis à l’examen et à l’approbation de sa demande d’autorisation de mise sur le marché (AMM) par l’Agence européenne des médicaments et la Commission européenne, respectivement. Le demande est en phase d’examen avancée pour...

Continue reading

Amarin kündigt Pläne zur Maximierung des Blockbuster-Potenzials von VASCEPA® (Icosapent-Ethyl) in Europa an

Amarin baut engagierte Organisation auf, um den erheblichen Wert eines der am meisten erwarteten kardiovaskulären Arzneimittel seit Jahrzehnten zu erhaltenErfahrene Führungskraft im Bereich der Vermarktung von kardiovaskulären Arzneimittel wurde eingestellt, um die fokussierte Markteinführung zu leitenDUBLIN, Irland und BRIDGEWATER, New Jersey, Aug. 06, 2020 (GLOBE NEWSWIRE) — Die Amarin Corporation plc (NASDAQ: AMRN) hat heute die Pläne des Unternehmens bekanntgegeben, die fokussierte Markteinführung von VASCEPA® (Icosapent-Ethyl) in Europa selbst voranzutreiben. Der Plan von Amarin unterliegt der Überprüfung und Genehmigung seines Zulassungsantrags (MAA) durch die Europäische Arzneimittel-Agentur bzw. die Europäische Kommission. Der Antrag befindet sich in einem späten Stadium der Überprüfung in Bezug auf die Reduzierung des kardiovaskulären...

Continue reading

Financial Results for Fiscal 2021 First Quarter Ended June 30, 2020

Revenues at $3.391 billion, down 7.6%Adjusted EBITDA at $366.5 million, up 2.4%Net earnings at $141.9 million, up 16.9%Adjusted net earnings at $160.9 million, down 2.4%MONTREAL, Aug. 06, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) reported today its financial results for the first quarter of fiscal 2021, which ended on June 30, 2020. All amounts in this news release are in Canadian dollars (CDN), unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).Revenues amounted to $3.391 billion, a decrease of $277.6 million or 7.6%.Adjusted EBITDA* amounted to $366.5 million, an increase of $8.5 million or 2.4%.Net earnings totalled $141.9 million and EPS** (basic and diluted) were $0.35, as compared to $121.4 million and EPS (basic and diluted) of $0.31.Adjusted...

Continue reading

Résultats financiers du premier trimestre de l’exercice clos le 30 juin 2020

Produits de 3,391 milliards de dollars, en baisse de 7,6 %BAIIA ajusté de 366,5 millions de dollars, en hausse de 2,4 %Bénéfice net de 141,9 millions de dollars, en hausse de 16,9 %Bénéfice net ajusté de 160,9 millions de dollars, en baisse de 2,4 %MONTRÉAL, 06 août 2020 (GLOBE NEWSWIRE) — Saputo inc. (TSX: SAP) (Saputo ou la Société) a divulgué aujourd’hui ses résultats financiers pour le premier trimestre de l’exercice financier 2021, clos le 30 juin 2020. À moins d’avis contraire, tous les montants inclus dans ce communiqué de presse sont exprimés en dollars canadiens (CAD) et sont présentés conformément aux Normes internationales d’information financière (IFRS).Les produits ont totalisé 3,391 milliards de dollars, en baisse de 277,6 millions de dollars, ou 7,6 %.Le BAIIA ajusté* s’est élevé à 366,5 millions de dollars, en hausse...

Continue reading

Financial Results for Fiscal 2021 First Quarter Ended June 30, 2020

Revenues at $3.391 billion, down 7.6%Adjusted EBITDA at $366.5 million, up 2.4%Net earnings at $141.9 million, up 16.9%Adjusted net earnings at $160.9 million, down 2.4%MONTREAL, Aug. 06, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) reported today its financial results for the first quarter of fiscal 2021, which ended on June 30, 2020. All amounts in this news release are in Canadian dollars (CDN), unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).Revenues amounted to $3.391 billion, a decrease of $277.6 million or 7.6%.Adjusted EBITDA* amounted to $366.5 million, an increase of $8.5 million or 2.4%.Net earnings totalled $141.9 million and EPS** (basic and diluted) were $0.35, as compared to $121.4 million and EPS (basic and diluted) of $0.31.Adjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.